Building on insights from her work as a graduate student adapting the Belcher Lab’s signature bacteriophage delivery platform, alum Uganda Tsedev has co‑launched Gensaic. The company’s AI‑powered platform helps guide design of precision protein “shuttles” that deliver therapeutic molecules to target tissues. This tissue‑selective approach could transform treatments for metabolic and other diseases while reducing side effects.